This innovative anti-ApoE conjugated liposome, designed as an immunoliposome (IL), has shown promise in selectively binding to activated human coronary artery endothelial cells (HCAEC). By leveraging this targeting mechanism, the liposome could enhance the imaging capabilities of computed tomography, facilitating the early detection of atherosclerotic plaques before they lead to significant cardiovascular events. The potential application of this imaging agent represents a significant advancement in cardiovascular diagnostics, offering a non-invasive method to assess and monitor arterial health.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NABL-072 | Recombinant Anti-human APOE VHH Single Domain Antibody | WB, IHC, FC, FuncS | Llama VHH |
There are currently no Customer reviews or questions for VS-1024-FY13. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.